Affiliation:
1. Pharma Nord (UK) Ltd., Morpeth, Northumberland NE61 2DB, UK
2. School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Merseyside L3 5UX, UK
Abstract
To date, there have been no review articles specifically relating to the general efficacy and safety of coenzyme Q10 (CoQ10) supplementation in younger subjects. In this article, we therefore reviewed the efficacy and safety of CoQ10 supplementation in neonates (less than 1 month of age), infants (up to 1 year of age) and children (up to 12 years of age). As there is no rationale for the supplementation of CoQ10 in normal younger subjects (as there is in otherwise healthy older subjects), all of the articles in the medical literature reviewed in the present article therefore refer to the supplementation of CoQ10 in younger subjects with a variety of clinical disorders; these include primary CoQ10 deficiency, acyl CoA dehydrogenase deficiency, Duchenne muscular dystrophy, migraine, Down syndrome, ADHD, idiopathic cardiomyopathy and Friedreich’s ataxia.
Reference100 articles.
1. Hargreaves, I., Heaton, R.A., and Mantle, D. (2020). Disorders of Human Coenzyme Q10 Metabolism: An Overview. Int. J. Mol. Sci., 21.
2. Mantle, D., Millichap, L., Castro-Marrero, J., and Hargreaves, I.P. (2023). Primary Coenzyme Q10 Deficiency: An Update. Antioxidants, 12.
3. Depletion and Supplementation of Coenzyme Q10 in Secondary Deficiency Disorders;Mantle;Front. Biosci. (Landmark Ed.),2022
4. Age-related changes in the lipid compositions of rat and human tissues;Appelkvist;Lipids,1989
5. Clinical and molecular investigation of 37 Japanese patients with multiple acyl-CoA dehydrogenase deficiency: P.Y507D in ETFDH, a common Japanese variant, causes a mortal phenotype;Yamada;Mol. Genet. Metab. Rep.,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献